Intra-Uterine Contraceptive Devices Market is Expected to reach a Market Value of USD 5.29 billion by 2026

Intra-Uterine Contraceptive Devices Market is forecasted to grow at 3.70% for 2019-2026 with factors such as religious oppositions and infertility recalls will hamper the growth of the market in emerging economies.

Intra-uterine contraceptive devices market has shown an exceptional penetration in developed economies of Europe. Rising awareness regarding safety and efficacy, increasing incidence of unintended pregnancies will boost the growth of the market.

Intra-Uterine Contraceptive Devices Market Scenario

According to Data Bridge Market Research the intra-uterine contraceptive devices market is witnessing a significant growth in the forecast period of 2019-2026 due to factors such as increasing incidence of unintended pregnancies, rising initiatives for the adoption of medical devices and increasing awareness regarding the usage of contraceptives will uplift the growth of the market.

Now the question is which are the other regions that intra-uterine contraceptive devices market is targeting? Data Bridge Market Research has forecasted a large growth in Asia-Pacific intra-uterine contraceptive devices market and the market leaders targeting China and India to be their next revenue pockets for 2020. The Data bridge market research new reports highlight the major growth factors and opportunities in the intra-uterine contraceptive devices market.

For More Analysis on the intra-uterine contraceptive devices market request for a briefing with our analysts

New Intra-Uterine Contraceptive Devices Market Developments in 2019

  • In October 2019, Medicines360 and Allergan announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) that will help in the prevention of pregnancy for a period of six years while provides flexibility and choice to the women’s reproductive health.

Scope of the Intra-Uterine Contraceptive Devices Market

Intra-uterine contraceptive devices market is segmented on the basis of countries into U.S., Canada, Mexico in North America, Brazil, Argentina, Rest of South America as a part of South America, Germany, France, U.K., Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Rest of Europe in Europe, China, Japan, India, Australia, Singapore, Thailand, Malaysia, South Korea, Indonesia, Philippines, Rest of Asia-Pacific (APAC)as a part of Asia-Pacific (APAC), U.A.E, Egypt, Saudi Arabia, South Africa, Israel,  Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country based analysis of the intra-uterine contraceptive devices market is further analyzed based on maximum granularity into further segmentation. On the basis of type, the market is segmented into hormonal IUCD and copper IUCD. Based on products, the market is segmented into mirena, skyla, paragard, essure, levosert and others. Based on distribution channel, the market is segmented into direct tenders and retail. The end-users covered for the report are hospitals, gynecology clinics, community healthcare.
  • Intrauterine contraceptive device is a type of medical device which is used to prevent pregnancy by placing it in the women’s uterus. The device is used to kill sperms or make them immobile which prevents the fertilization of egg.

To know more about the study

Key Pointers Covered in the Intra-Uterine Contraceptive Devices Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • Teva Pharmaceutical Industries Ltd.
  • Mona Lisa N.V.
  • OCON Medical Ltd.
  • Pregna International Limited.
  • Medical Engineerign Corporation S.A.
  • SMB Corporation of India
  • Meril Life Sciences Pvt. Ltd.
  • Limited and licensors.
  • Bernstein Liebhard LLP.
  • A.M.E. bvba
  • Technico Industries Ltd.
  • LTS Lohmann Therapie-Systeme AG,

Above are the key players covered in the report, to know about more and exhaustive list of Intra-Uterine Contraceptive Devices companies contact us

Research Methodology: Global Intra-Uterine Contraceptive Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@